Skip to main content
Caplight Logo









ArzonApteka

ArzonApteka

Private
TashkentHealthcare & Life Scienceshttps://arzonapteka.uz/uz

Last Round

Early Funding

Aug 22, 2024

Total Funding Raised

$7.14M

Company Overview

ArzonApteka operates in Healthcare & Life Sciences and is based in Tashkent. Its latest recorded funding round was an Early Funding round in August 2024.

ArzonApteka is a health-tech company that provides a digital platform for searching, comparing, and ordering pharmaceutical products from pharmacies across Uzbekistan.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Retail Technology, Mobile Commerce, E-commerce

Business Model

B2B2C

Customer Profile

Marketplace Commission, Subscription SaaS, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ArzonApteka Comparables

Compare ArzonApteka with similar companies based on industry and business-model similarity.

ArzonApteka comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apteka.uz
91%
OSON APTEKA LLC
90%
Uteka
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ArzonApteka Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 22, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

ArzonApteka Investors

Notable investors and investment history

ArzonApteka investors
InvestorRounds
Sturgeon CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 154% MoM, reaching 270.2K.

  • Apr 3, 2026

    Monthly visitors increased 47% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

ArzonApteka Filings

Explore SEC and related filing metadata, where available.

ArzonApteka filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ArzonApteka's valuation, stock price, and market status.

Is ArzonApteka a public or private company?

ArzonApteka is a private company.

What is the current stock price of ArzonApteka?

ArzonApteka is a private company, so its shares have no public market price. Caplight tracks ArzonApteka's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ArzonApteka worth (valuation)?

Valuation information for ArzonApteka is not publicly available.

Can I buy ArzonApteka stock?

ArzonApteka shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ArzonApteka's last funding round?

ArzonApteka's most recent funding round was Early Funding on August 22, 2024.

Who are the main investors in ArzonApteka?

Key investors in ArzonApteka include Sturgeon Capital.

Will ArzonApteka IPO soon?

No public IPO plans have been announced for ArzonApteka.

How can I track ArzonApteka secondary market activity?

Caplight tracks bids, offers, and trades in ArzonApteka's shares on secondary markets.

Firmographic Details

HeadquartersTashkent
Year Founded2016
Last FundingAug 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?